OClawVPS.com
Edit

Femmes Business Angels

https://www.femmesbusinessangels.org
Last activity: 02.11.2025
Probably Closed
Invests in categories: ServiceAppSaaSHealthTechTechnologySportsSmartProductPlatformProduction
Portfolio
155
Persons
18
Mentions
5
Location: France, Ile-de-France, Drancy
Employees: 11-50
Investment Stage: Seed

Portfolio 155

DateNameWebsiteTotal RaisedLocation
01.10.2025Seabelife ...seabelife.com$5.11MFrance
10.11.2023MerciYanismerciyanis.com-France, Oc...
10.11.2023Outmindoutmind.ai$2.56MFrance, Il...
10.11.2023Kuragekurage.fr-Metropolit...
10.11.2023Matatiematatie.com--
10.11.2023Cearitiscearitis.com-France, Pr...
10.11.2023Falco - Wa...wefalco.com-France, Il...
10.11.2023Ingainga.eco-Finland, M...
10.11.2023Les Petits...lespetitsbidons.fr-France, Il...
10.11.2023Debongoutdebongout-paris.com-France, Il...
Show more

Persons 18

DateFirst NameLast NameTitleLinkedInLocation
-PatriciaNiegoAdministra...linkedin.c...-
-SylvaineAudrainAdministra...linkedin.c...-
-CatheLamarqueVICE-PRESI...linkedin.c...-
-DominiqueMucchielliTRESORIERElinkedin.c...-
-FrançoiseHuguet-Dev...Vice-PrEsi...-
-FlorenceRichardsonAdministra...linkedin.c...-
-JohannahGayAdministra...linkedin.c...-
-SonjaFellAdministra...linkedin.c...-
-RadhiaAmiratAdministra...linkedin.c...-
-GenevièveLauransAdministra...linkedin.c...-
Show more

Mentions in press and media 5

DateTitleDescription
03.10.2025French Biotech SeaBeLife Secures €2 Million to Tackle Dry AMD and Severe Acute HepatitisFrench biotech SeaBeLife secures €2 million in a pre-Series A funding round. This capital accelerates groundbreaking drug development for severe acute hepatitis and dry age-related macular degeneration (AMD). The company pioneers a unique, ...
03.10.2025SeaBeLife: €2 Million Pre-Series A Secured To Advance Clinical Trials In Dry AMD And Severe Acute HepatitisSeaBeLife, a biotechnology company focused on developing innovative drug candidates designed to inhibit cellular necrosis, has closed a pre-Series A funding round, raising €2 million ($2.25 million). The investment was led by the historical...
01.10.2025French BioTech developer SeaBeLife raises €2 million to tackle dry AMD and severe acute hepatitisRoscoff-based SeaBeLife, a BioTech company developing innovative drug candidates intended to block cellular necrosis, today announces a pre-Series A funding round worth €2 million. The financing was led by historical investor iXLife, alongs...
01.10.2025French biotech SeaBeLife raises €2M to treat liver and eye diseasesFrench biotech company SeaBeLife has secured €2 million in a pre-Series A funding round to advance its drug development pipeline, with clinical trials expected to begin in 2026. The financing, led by existing investor iXLife and joined by n...
20.04.2023French HR tech start-up Spayr raises €2.5 million to help employees get an advance on payFrench HR tech start-up Spayr has raised a €2.5 million Seed funding round led by Blast.Club and includes FBA (Femmes Business Angels) and other fintech angel investors. Spayr's platform provides access to part of already earned salaries in...

Reviews 0

Sign up to leave a review

Sign up Log In